That doesn't include the US $ 40 million (NT $ 14 billion) Phase III clinical trials (which require at least one thousand participants) and the US $ 20 million it will take to put the drug into production and get it to market.
這還不包括未來第三期臨床試驗（受試人數至少需要千人以上）所需的 4,000 萬美元，以及量產上市前的 2,000 萬美元，總共還需 21 億台幣。